血液透析（MHD）和腹膜透析（cAPD是现代公认的终末期肾功衰竭的替代治疗方法。这两种方法均能延长生存期和提高生活质量。但是关于两种透析方式在预防发病和降低病死率方面是否有相同的效果还有很大争论。透析患者普遍存在营养不良，大量报道表明对于长期透析病人的患病率和病 Both hemodialysis (MHD) and peritoneal dialysis (cAPD) are well-established surrogate treatments for end-stage renal failure, both of which can prolong survival and improve quality of life, but the two dialysis modalities have been used to prevent morbidity and mortality There is still much debate on whether there is the same effect on the rate of malnutrition prevalence of dialysis patients, a large number of reports indicate that for the long-term dialysis patients prevalence and disease